Treatment

CART4-34 therapy

Oncologic Therapy

CART4-34 therapy is an experimental chimeric antigen receptor T cell treatment that targets the IGHV4-34 B cell receptor, developed to treat certain B-cell lymphomas and autoimmune diseases such as systemic lupus erythematosus. A patient's own T cells are modified to express a chimeric antigen receptor based on the 9G4 antibody, which binds IGHV4-34 on malignant or disease-causing B cells; because IGHV4-34 appears on only about five percent of normal B cells, CART4-34 is designed to spare most healthy B cells, unlike CD19-targeted CAR T therapies, which eliminate a much broader population of B cells and suppress the immune system more broadly. As of 2026, CART4-34 remains in preclinical development, with cell-line and mouse-model studies reporting cancer-killing effects similar to CD19 CAR T therapy but with reduced off-target damage, and plans for phase 1 trials in lymphoma and lupus.

Facts
Classification
Status
Standard of Care 1
Origin Year
2023 2
FAQs

How is CART4-34 different from CD19 CAR T therapy?

It targets IGHV4-34 rather than CD19 and is designed to spare most healthy B cells.

CD19 CAR T therapy targets a marker found on both healthy and disease-causing B cells, so it eliminates B cells even when they are not harmful. CART4-34 instead targets the IGHV4-34 B cell receptor, and it is designed to spare most healthy B cells.
Connections

Treats

Source CART4-34 therapy (Wikipedia)
Sources
1. Wikipedia
Wikipedia contributors, Wikimedia Foundation
  • Status: Standard of Care
2. CART4-34 therapy (Wikipedia)
  • https://en.wikipedia.org/wiki/CART4-34_therapy, lead section
    CART4-34 therapy is an experimental chimeric antigen receptor T cell therapy that targets the IGHV4-34 B cell receptor.
  • Section: History (origin-year)
    University of Pennsylvania researchers first presented CART4-34 in 2023.
  • Treats: Systemic Lupus Erythematosus, Lead: treats Systemic Lupus Erythematosus
    It attempts to treat certain B-cell lymphomas and autoimmune diseases such as systemic lupus erythematosus (SLE).
View the Source
Comments (0)
No comments yet. Be the first to share a thought.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.

View At A Past Year

Choose a year to see this entry's facts and connections as the atlas records them at that moment: what it held then, what it held instead, and what it had not yet adopted. Choose Present for the current record.

Medicine Atlas

How Healing Is Practiced
Sign In
Text size
100%
Theme